Target intelligence / Profile preview

Glucosylceramidase beta 1 like, pseudogene (GBA1LP)

Target
GBA1LP
Molecular classification
Pseudogene, Not part of enzyme, receptor, transporter, transcription factor, or ion channel families
01

Overview

Glucosylceramidase beta 1 like, pseudogene (GBA1LP) is a non-protein-coding pseudogene located near the GBA1 gene on chromosome 1[1][5]. While GBA1 encodes a lysosomal enzyme crucial for glycolipid metabolism and is directly linked to disorders such as Gaucher disease, GBA1LP does not encode a functional protein. However, GBA1LP shares high sequence similarity with GBA1 and may influence disease risk or expression through transcript regulation or competitive binding of regulatory miRNAs[3][5]. Pseudogenes such as GBA1LP are increasingly recognized for their potential regulatory but non-coding roles in cell biology and disease, though they are not considered classical drug targets.

Other names
GBA1LPglucosylceramidase beta 1 like, pseudogeneGBAP1 (sometimes used, although GBAP1 and GBA1LP may refer to related but non-identical loci)
02

Mechanism of action

None known; does not encode a protein target for direct pharmacological action

03

Biological functions

May act as a non-coding RNA (regulatory function)Possible involvement in cell-specific transcript regulation (e.g., sequestering microRNAs that target GBA1)Not directly involved in known cellular biochemical pathways as a protein
04

Disease associations

Potential disease-modifying effects, e.g., by influencing GBA1 expressionImplicated in modifying risk or progression of diseases linked to GBA1, such as Gaucher disease and Parkinson's disease, due to sequence similarity and transcript regulationMay be involved in cancer biology as a miRNA sink or regulator (e.g., reported contribution to gastric cancer progression)

Beyond the preview

Go deeper on Glucosylceramidase beta 1 like, pseudogene (GBA1LP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucosylceramidase beta 1 like, pseudogene (GBA1LP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call